Currently, Kobayashi Pharmaceutical’s headquarters in Tokyo is gearing up for an urgent shareholders meeting.


    In an unexpected turn of events, Jiro Kobayashi, the chairman of Kobayashi Pharmaceutical Co., Ltd., vanished shortly after his trip to China. This sudden disappearance left the entire Kobayashi Pharmaceutical Group without leadership.


    Initially, the shareholders of Kobayashi Pharmaceuticals were determined to locate Jiro Kobayashi and employed various methods in their search.


    Despite their considerable efforts, they were unable to uncover any information regarding his whereabouts.


    In light of this, they reached out to Ito Takehiko, the head of the Ito family.<h3 style="background-color:DodgerBlue">


    The shareholders contacted Ito Yuhiko, knowing his positive outlook on both Kobayashi Pharmaceuticals and Jiro Kobayashi. They were aware that Ito Yuhiko had aspirations of marrying Jiro Kobayashi to his daughter, Nanako Ito, and was interested in acquiring shares in thepany.


    Ultimately, Jiro Kobayashi’s trip to China was to pursue a rtionship with Nanako Ito.


    However, while Nanako Ito returned, Jiro Kobayashi seemed to havepletely vanished, leaving the Kobayashi family in a state of confusion.


    Ito Yuhiko was also quite concerned about the situation. His optimism for Jiro Kobayashi and Kobayashi Pharmaceutical made Jiro’s disappearance particrly rming, especially since he hoped Jiro would be his son-inw.


    Moreover, the production capacity of Oracle Nova Dias is currentlycking, and it has not yet entered overseas markets. Consequently, local consumers in Japan remain unaware of this innovative medicine, continuing to regard Kobayashi Niranex as the leading stomach remedy. Sales for Kobayashi Niranex in Japan have remained unaffected.


    From Ito’s perspective, the future of Kobayashi Pharmaceutical still appears promising.


    To seize the investment opportunity in Kobayashi Pharmaceutical, Ito Yuhiko dispatched numerous individuals to search for Jiro Kobayashi.


    Unfortunately, theirck of a robust intelligencework in China hindered their ability to gather any information on Jiro Kobayashi.


    As time passed, Jiro Kobayashi seemed to havepletely vanished from the views of both the Kobayashi family and Ito Yuhiko.


    Eventually, Ito Yuhiko decided to cease the search for Jiro Kobayashi.


    He concluded that it would be more beneficial for the Kobayashi family to quickly select a new president instead of continuing the search.


    Following this, under Ito Takehiko’s guidance, the Kobayashi family also relinquished their search for Jiro Kobayashi.


    With the search concluded, they shifted focus to the next stage: preparing to reform Kobayashi Pharmaceutical and redistribute its assets.


    Kobayashi Pharmaceutical was established over decades by Masao Kobayashi, the father of Ichiro Kobayashi. Despite many family members being involved, they do not directly own shares in thepany.


    After Masao Kobayashi’s passing, Ichiro Kobayashi faced usations of being a father-killer, leaving Jiro Kobayashi as the sole heir to Kobayashi Pharmaceutical.


    However, with Jiro now missing, the situation has changed.


    ording to Japanesew, if Jiro Kobayashi’s whereabouts remain unknown for a specific period, he can be legally dered dead, and his rtives will inherit his assets.


    This would mean that all shares of Kobayashi Pharmaceutical could potentially be imed by the coteral rtives of the Kobayashi family.


    In the meantime, Ichiro Kobayashi’s uncle, Masayoshi Kobayashi, has stepped in as the acting chairman of Kobayashi Pharmaceutical Co., Ltd., managing thepany in Jiro Kobayashi’s absence.


    Ito Yuhiko, who has long desired shares in Kobayashi Pharmaceutical, has now turned his attention towards Masayoshi Kobayashi.<fnb516> The source of th?s content is </fnb516>